April 24, 2014 4:47 PM ET

Pharmaceuticals

Company Overview of Oculex Pharmaceuticals, Inc.

Executive Profile

Donald J. Eaton

Chairman of the Board and Chief Executive Officer., Oculex Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
75--

Background

Donald J. Eaton has been Chairman and Chief Executive Officer of Oculex Pharmaceuticals, Inc. since March 2000. Mr. Eaton served as consultant of Oculex Pharmaceuticals, Inc. from April 1999 to March 2000. Prior to that, Mr. Eaton was the founder of Mimetix, Inc. and served as its Chairman of the Board and Chief Executive Officer from 1992 to 1998. Mr. Eaton was Founder of Summa Care, Inc., a developer of dermatological products, and served as its Chief Executive Officer ...

Corporate Headquarters

601 West California Avenue
Sunnyvale, California 94086

United States

Phone: 408-481-0424
Fax: 408-481-0662

Board Members Memberships

Chairman of the Board and Chief Executive Officer.

Education

JD
Santa Clara University
BS
Santa Clara University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Oculex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.